Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole Pulse Therapy vs Topical Ketoconazole for Scalp Seborrheic Dermatitis
NCT07734441Phase 1Recruiting
- Start
- Jan 2026
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of itraconazole in seborrheic dermatitis (SD) (2 arms). Primary endpoint: Seborrheic Dermatitis Severity Score at 6 months. Started Jan 2026; status: recruiting.
02
Drugs
itraconazole
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on NCT07734441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07734441.